Clinical Trials › NCT06733922
RecruitingPhase 4
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Sponsored by Novartis Pharmaceuticals
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 224
Target enrollment
Nov 2024
Start date
Nov 2027
Expected completion
Interventions / Treatments
ETNATM-ProgMS
Conditions studied
Relapsing Remitting Multiple Sclerosis (RRMS)
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 4 trials
Browse all Phase 4 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.